The overall results highlighted an interesting translational comparability between the tumor biology of human and canine osteosarcoma and a potential utility of targeting BMI1 in CSCs of this malignancy to overcome the challenge of DR in response to first-line chemotherapeutics [40]. This evidence concerns the gene BMI1 and osteosarcoma.